Clinical Trials Browser

Carcinoma × Bevacizumab × Thoracic × Clear all

NCT00666692 2012-04-27

A Phase 1b Study With Volociximab in Combination With Carboplatin, Paclitaxel, and Bevacizumab in First-line, Advanced Non-small Cell Lung Cancer (NSCLC)

Phase 1 Completed

Carcinoma, Carcinoma, Non-Small-Cell Lung, Neoplasms